tm100; $17B is a bargain for "V". Just look at Annual Sales of Lipitor $10B!! And this was just the US market. Amarin has Europe (IMHO) and soon to have China (IMHO). Vazkepa could be the highest selling drug of all time and Amarin is letting it go for peanuts?
Don't get me wrong, I definitely would be over-joyed with $42.50 per share, but IMHO Vascepa is worth much more than that. Especially for all the angst it has put all of us through. Not counting the management team and others with bigger investments.